RecombiMAb anti-mouse Ly6G抗體-自主發布-資訊-生物在線

RecombiMAb anti-mouse Ly6G抗體

作者:欣博盛生物科技有限公司 暫無發布時間 (訪問量:10695)

BioXCell熱銷產品--RecombiMAb anti-mouse Ly6G

 

產品描述:

1A8-CP129單克隆抗體是原始1A8單克隆抗體的重組嵌合型抗體。可變結構域序列與原始1A8相同,但是恒定區序列已經從大鼠IgG2a變為小鼠IgG2a。1A8-CP129單克隆抗體像原始克隆號的大鼠IgG2a抗體一樣,不包含Fc突變。

 

1A8-CP129單克隆抗體與小鼠Ly6G反應。Ly6G分子量為21-25kDa,是GPI錨定的細胞表面蛋白Ly-6超家族的成員,在細胞信號傳導和細胞粘附中發揮作用。Ly6G在發育過程中由骨髓譜系中的細胞(包括單核細胞、巨噬細胞、粒細胞和嗜中性粒細胞)差異表達。單核細胞通常在發育過程中瞬時表達Ly6G,而成熟的粒細胞和外周嗜中性粒細胞持續表達,使Ly6G成為這些細胞群體的表面標志物。與BioXcell RB6-8C5單克隆抗體不同,1A8-CP129單克隆抗體與小鼠Ly6G特異性反應,而與Ly6C沒有交叉反應性的報道。

BioXCell熱銷產品--RecombiMAb anti-mouse Ly6G

 

 

產品詳情:

產品名稱

RecombiMAb anti-mouse Ly6G

產品貨號

CP129

產品規格

1/5/25/50/100mg

反應種屬

Mouse

克隆號

1A8-CP129

同種型

Mouse IgG2a(switched from rat IgG2a)

免疫原

EL4J cells transfected with Ly6G

實驗應用

in vivo neutrophil depletion*

in vivo MDSC depletion*

Immunofluorescence*

Immunohistochemistry (paraffin)*

Immunohistochemistry (frozen)*

Flow cytometry*

*Reported for the original rat IgG2a 1A8 antibody

產品形式

PBS, pH 7.0,Contains no stabilizers or preservatives

純度

>95%, Determined by SDS-PAGE

聚合

<5%, Determined by SEC

無菌處理

0.2 µm filtration

純化方式

Protein G

分子量

150 kDa

小鼠病原檢測

Ectromelia/Mousepox Virus: Negative

Hantavirus: Negative

K Virus: Negative

Lactate Dehydrogenase-Elevating Virus: Negative

Lymphocytic Choriomeningitis virus: Negative

Mouse Adenovirus: Negative

Mouse Cytomegalovirus: Negative

Mouse Hepatitis Virus: Negative

Mouse Minute Virus: Negative

Mouse Norovirus: Negative

Mouse Parvovirus: Negative

Mouse Rotavirus: Negative

Mycoplasma Pulmonis: Negative

Pneumonia Virus of Mice: Negative

Polyoma Virus: Negative

Reovirus Screen: Negative

Sendai Virus: Negative

Theiler’s Murine Encephalomyelitis: Negative

保存條件

抗體原液保存在4°C,不能冷凍保存。

推薦同型對照

InVivoPlus mouse IgG2a isotype control, unknown specificity(貨號BP0085)

推薦抗體稀釋液

InVivoPure pH 7.0 Dilution Buffer(貨號IP0070)

 

該產品自上市已被多篇SCI文獻引用,品質有保證,以下是部分已發表的文獻引用:

應用

文章

體內中性粒細胞耗竭

(in vivo neutrophil depletion)

1. Davis, R. W. t., et al. (2018). 'Luminol Chemiluminescence Reports Photodynamic 

Therapy-Generated Neutrophil Activity In Vivo and Serves as a Biomarker of Therapeutic 

Efficacy' Photochem Photobiol .

2. Moynihan, K. D., et al. (2016). 'Eradication of large established tumors in mice by 

combination immunotherapy that engages innate and adaptive immune responses' Nat Med. 

doi : 10.1038/nm.4200.

3. Conde, P., et al. (2015). 'DC-SIGN(+) Macrophages Control the Induction of Transplantation 

Tolerance' Immunity 42(6): 1143-1158.

4. Griseri, T., et al. (2015). 'Granulocyte Macrophage Colony-Stimulating Factor-Activated 

Eosinophils Promote Interleukin-23 Driven Chronic Colitis' Immunity 43(1): 187-199.

5. Yamada, D. H., et al. (2015). 'Suppression of Fcgamma-receptor-mediated antibody 

effector function during persistent viral infection' Immunity 42(2): 379-390. 

體內中性粒細胞耗竭、流式細胞術、

免疫組化石蠟切片(in vivo neutrophil 

depletion, Flow Cytometry, 

Immunohistochemistry (paraffin))

Coffelt, S. B., et al. (2015). 'IL-17-producing gammadelta T cells and neutrophils conspire 

to promote breast cancer metastasis' Nature 522(7556): 345-348.

體內中性粒細胞耗竭、流式細胞術、

免疫組化石蠟切片、免疫組化冰凍切片

(in vivo neutrophil depletion, Flow 

Cytometry, Immunohistochemistry 

(paraffin), Immunohistochemistry (frozen)

Finisguerra, V., et al. (2015). 'MET is required for the recruitment of anti-tumoural 

neutrophils' Nature 522(7556): 349-353.

體內中性粒細胞耗竭、流式細胞術

(in vivo neutrophil depletion, 

Flow Cytometry)

1.Moser, E. K., et al. (2014). 'Late engagement of CD86 after influenza virus 

clearance promotes recovery in a FoxP3+ regulatory T cell dependent manner' 

PLoS Pathog 10(8): e1004315.

2. Chen, K. W., et al. (2014). 'The neutrophil NLRC4 inflammasome selectively 

promotes IL-1beta maturation without pyroptosis during acute Salmonella 

challenge' Cell Rep 8(2): 570-582.

3. Garraud, K., et al. (2012). 'Differential role of the interleukin-17 axis and 

neutrophils in resolution of inhalational anthrax' Infect Immun 80(1): 131-142.

體內骨髓來源抑制細胞耗竭

(in vivo MDSC depletion)

Deng, L., et al. (2014). 'Irradiation and anti-PD-L1 treatment synergistically 

promote antitumor immunity in mice' J Clin Invest 124(2): 687-695.

體內中性粒細胞耗竭、

免疫熒光(in vivo neutrophil 

depletion, Immunofluorescence)

Edelson, B. T., et al. (2011). 'CD8alpha(+) dendritic cells are an obligate 

cellular entry point for productive infection by Listeria monocytogenes' 

Immunity 35(2): 236-248.

 

BioXCell熱銷產品--RecombiMAb anti-mouse Ly6G

更多產品詳情請咨詢 BioXCell 中國授權代理——欣博盛生物

全國服務熱線: 4006-800-892       郵箱: market@neobioscience.com 

深圳: 0755-26755892         北京: 010-88594029            

廣州:020-87615159           上海: 021-34613729

代理品牌網站: www.neobioscience.com 

自主品牌網站: www.neobioscience.net

欣博盛生物科技有限公司 商家主頁

地 址: 深圳福田區梅華路105號多麗工業區科技樓605

聯系人: Miss Yao

電 話: 0755-26755892(深圳) 010-88594029(北京) 021-34613729(上海) 020-87615159 (廣州)

傳 真: 0755-26755877

Email:market@neobioscience.com

相關咨詢
ADVERTISEMENT